Biomarker Discovery May Lead to New Treatments for People with ... | Biomarkers and Personalized Medicine | Scoop.it
A team of neuroscientists from Harvard Medical School have discovered that changes in monocytes are a biomarker for amyotrophic lateral sclerosis, possibly finding a new target for developing treatments for people with ALS ...